⌘K
Loading ticker…
As of 2026-08-25, Medifast, Inc. (MED) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 52.9 (Neutral). Sector: Consumer Staples, ranked 8 of 11. Average daily range 4.4%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MED is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 11.1% / 9.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
MED is held by 20 ETFs as of May 2026. Top owner: FNDA at 0.05% weight, $5M notional. Top 3 carry $9M.
Held by 40 ETFs · $25M across latest filings · largest weight 0.29% (SVAL).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FNDA | 0.05% | $5M | — |
| AVUVAvantis U.S. Small Cap Value ETF | 0.01% | $3M | — |
| VDCVanguard Consumer Staples ETF | 0.02% | $2M | — |
| VTWO | 0.00% | $696K | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $638K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| FSCC | 0.13% | $357K | −0.01 pp |
| AVSC | 0.01% | $209K | — |
| VFMF | 0.02% | $142K | new |
| GSSC | 0.01% | $116K | — |
| VTWV | 0.01% | $104K | — |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MED Jan avg: -6.46% median: -7.14% win: 25% σ: 11.00% n: 4 2022-04-12 → 2026-07-31 | MED Feb avg: -10.63% median: -8.24% win: 25% σ: 11.46% n: 4 2022-04-12 → 2026-07-31 | MED Mar avg: -5.33% median: -5.27% win: 0% σ: 1.90% n: 4 2022-04-12 → 2026-07-31 | MED Apr avg: -7.51% median: -2.52% win: 20% σ: 13.23% n: 5 2022-04-12 → 2026-07-31 | MED May avg: -0.96% median: -6.50% win: 40% σ: 11.86% n: 5 2022-04-12 → 2026-07-31 | MED Jun avg: -1.07% median: -0.14% win: 40% σ: 14.33% n: 5 2022-04-12 → 2026-07-31 | MED Jul avg: -1.02% median: -1.99% win: 40% σ: 7.27% n: 5 2022-04-12 → 2026-07-31 | MED Aug avg: -14.32% median: -16.89% win: 25% σ: 11.53% n: 4 2022-04-12 → 2026-07-31 (current) | MED Sep avg: -5.72% median: -6.91% win: 25% σ: 8.36% n: 4 2022-04-12 → 2026-07-31 | MED Oct avg: -3.92% median: -5.79% win: 25% σ: 8.59% n: 4 2022-04-12 → 2026-07-31 | MED Nov avg: 0.50% median: 1.50% win: 50% σ: 8.18% n: 4 2022-04-12 → 2026-07-31 | MED Dec avg: -5.07% median: -5.57% win: 25% σ: 5.37% n: 4 2022-04-12 → 2026-07-31 |